Cardiovascular Risk Evaluation and Antiretrovirals in HIV

Predicted 10-year Coronary Heart Disease Risk in HIV and Implications for Clinical Management: the CREATE Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01015092

Acronym

CREATE1

Enrollment

1024

Registered

2009-11-17

Start date

2005-06-30

Completion date

2006-11-30

Last updated

2009-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Risk, HIV Infections

Keywords

HIV, Cardiovascular, Coronary hear disease, HAART, antiretroviral

Brief summary

The purpose of the study is to determine the main factors contributing to predicted 10 year cardiovascular risk in an HIV infected cohort, and the role of anti-HIV drug use in altering this risk

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Serologically proven HIV infection * Attending general HIV outpatient clinic

Exclusion criteria

* Attending a specialist outpatient clinic which might lead to recruitment bias

Design outcomes

Primary

Measure	Time frame
10 year predicted cardiovascular risk	AT time of clinic attendence

Secondary

Measure	Time frame
coronary heart disease risk	at time of clinic attendence

Countries

United Kingdom

Outcome results